AOR Fem-Adapt - Flaxseed Soy Isoflavone & Black Cohosh Menopause Support | 60 Caps
Visit the AOR Store| Brand | AOR |
| Serving | 2 capsules daily (60 per bottle) |
| Licensed Natural Health Product | NPN 80034694 |
| Quality Standards | GMP-compliant facility |
| Country | Made in Canada  |
About this item
- Support during hot flashes and night sweats Fem-Adapt combines flaxseed, soy isoflavone, black cohosh and LIFENOL hops extracts, botanicals studied for comfort during the hormonal shifts of menopause.
- A 4-in-1 botanical blend Each 2-capsule serving provides flaxseed (Linum usitatissimum) extract 168 mg, soy isoflavone extract 60 mg (24 mg AIE), black cohosh extract 80 mg and LIFENOL hops extract 120 mg.
- For menopausal and post-menopausal women Formulated for the recommended use in menopausal and post-menopausal women, under Health Canada NPN 80034694.
- Simple, once-daily dose Take 2 capsules once daily - one 60-capsule bottle provides up to a 1-month supply.
- Vegan, Non-GMO, Gluten-free The capsule shell is hypromellose (vegan), with non-GMO sourcing and no gluten-containing ingredients.
- Advanced Orthomolecular Research Made by AOR, a Canadian supplement manufacturer formulating science-based natural health products since 1991.
- Made in Canada Manufactured in Canada to GMP-compliant quality standards.
Product description
AOR Fem-Adapt - Botanical Support for Menopause Symptoms
A 4-part botanical blend - flaxseed, soy isoflavone, black cohosh and LIFENOL hops extracts - in one vegan capsule, formulated to help relieve menopause symptoms in menopausal and post-menopausal women. Licensed Natural Health Product NPN 80034694.
Un mélange botanique en 4 parties - extraits de lin, d'isoflavones de soja, d'actée à grappes et de houblon LIFENOL - en une capsule végane, formulé pour aider à soulager les symptômes de la ménopause chez les femmes ménopausées et post-ménopausées.
Why AOR Fem-Adapt
Four real botanicals working together - not a single generic phytoestrogen extract.
A 4-in-1 botanical blend
Flaxseed (Linum usitatissimum), soy isoflavone, black cohosh and LIFENOL hops extracts are combined in one formula rather than relying on a single botanical.
The AOR difference
428 mg of combined botanical extracts per 2-capsule serving, vegan, non-GMO and gluten-free, made in Canada under a Health Canada Natural Health Product licence.
Advanced Ingredients, Superior Results
Four botanicals, each studied for a role in menopause support - flaxseed lignans, soy isoflavones, black cohosh and LIFENOL hops (8-prenylnaringenin).
Flaxseed Extract (Linum usitatissimum)
A concentrated 40:1 extract of flaxseed, a traditional plant source of lignans.
168 mg per serving (40:1 extract)Soy Isoflavone Extract
A standardized soy extract delivering 40% total isoflavones (24 mg Aglycone Isoflavone Equivalents), a class of plant compounds studied for menopause symptom support.
60 mg per serving (24 mg AIE)
Black Cohosh Extract (Actaea racemosa)
A 6-8:1 extract of black cohosh root, one of the most widely studied herbal ingredients for menopausal comfort.
80 mg per serving (6-8:1 extract)LIFENOL® Hops Extract (Humulus lupulus)
A standardized hop extract delivering the phytoestrogen 8-prenylnaringenin. LIFENOL® is a registered trademark of Naturex, Inc.
120 mg per serving (15-30:1 extract)AOR Fem-Adapt: Supplement Facts
Medicinal Ingredients (per 2 capsules)
- Flaxseed Extract (Linum usitatissimum) 40:1 extract168 mg
- Soy Isoflavone Extract standardized to 40% total isoflavones (24 mg AIE*)60 mg
- Black Cohosh Extract (Actaea racemosa) 6-8:1 extract80 mg
- LIFENOL® Hops Extract (Humulus lupulus) 15-30:1 extract120 mg
Non-Medicinal Ingredients: Microcrystalline cellulose, silicon dioxide, maltodextrin and tricalcium phosphate. Capsule: hypromellose. *AIE: Aglycone Isoflavone Equivalents. LIFENOL® is a registered trademark of Naturex, Inc.
Recommended Use or Purpose (menopausal and post-menopausal women): Helps relieve menopause symptoms.
Recommended Dose (menopausal and post-menopausal women): Take 2 capsules daily, or as directed by a qualified health care professional. Take a few hours before or after taking other medications or natural health products. Consult a health care practitioner for use beyond one year. Do not exceed daily dose unless instructed by a healthcare practitioner.
Cautions: Ensure you are up to date on mammograms and gynecological evaluations prior to use. Do not use if you are pregnant, if you currently have or previously had breast cancer or breast tumours, have a predisposition to breast cancer as indicated by an abnormal mammogram, biopsy or have a family member with breast cancer. This product contains corn and soy derived ingredients, do not use if you have such allergies.
Actual product packaging and materials may contain more and different information than shown on our website. Always read labels, warnings and directions before using or consuming a product. This item is sold and shipped by Amazon.ca; purchases are completed on Amazon.
Ingrédients médicinaux (par 2 capsules)
- Extrait de lin (Linum usitatissimum) extrait 40:1168 mg
- Extrait d'isoflavones de soja normalisé à 40 % d'isoflavones totales (24 mg AIE*)60 mg
- Extrait d'actée à grappes (Actaea racemosa) extrait 6-8:180 mg
- Extrait de houblon LIFENOL® (Humulus lupulus) extrait 15-30:1120 mg
Ingrédients non médicinaux : Cellulose microcristalline, dioxyde de silicium, maltodextrine et phosphate tricalcique. Capsule : hypromellose. *AIE : Équivalents d'isoflavones aglycones. LIFENOL® est une marque déposée de Naturex, Inc.
Usage ou fins recommandés (femmes ménopausées et post-ménopausées) : Soulage les symptômes de la ménopause.
Dose recommandée (femmes ménopausées et post-ménopausées) : Prendre 2 capsules par jour, ou selon les recommandations d'un professionnel de la santé qualifié. Prendre à quelques heures d'intervalle des autres médicaments ou produits de santé naturels. Consulter un praticien de la santé pour un usage de plus d'un an. Ne pas dépasser la dose quotidienne, sauf sur les conseils d'un praticien de la santé.
Mises en garde : Avant de prendre ce produit, assurez-vous que votre mammographie et vos consultations gynécologiques sont à jour. Ne prenez pas ce produit si vous êtes enceinte, si vous avez ou avez déjà eu des tumeurs cancéreuses ou un cancer du sein, si vous avez une prédisposition au cancer du sein selon les résultats d'une mammographie ou d'une biopsie anormale ou si vous avez des antécédents familiaux de cancer du sein. Ce produit contient des ingrédients dérivés du maïs et du soja, ne pas consommer si vous avez une allergie.
NPN 80034694
Get a 4-part botanical blend for menopause comfort and hormonal balance
Get AOR Fem-Adapt on Amazon.ca - fast, protected delivery.
Get it on Amazon.caWhy AOR Fem-Adapt
A 4-part botanical formula built for menopause comfort and hormonal balance.
Menopause Symptom Relief
Helps relieve menopause symptoms such as hot flashes and night sweats - the product's licensed Health Canada use.
4 Real Botanicals
Flaxseed, soy isoflavone, black cohosh and LIFENOL hops extracts, each included at a labelled dose rather than a proprietary blend.
Hormonal Balance Support
Formulated for women navigating the hormonal shifts of menopause and post-menopause.
Clean, Vegan Formula
Vegan, non-GMO and gluten-free, made in Canada in a GMP-compliant facility.
Inside every serving
A 4-part botanical blend per 2-capsule serving: flaxseed (Linum usitatissimum) extract 168 mg, soy isoflavone extract 60 mg (24 mg AIE), black cohosh extract 80 mg and LIFENOL hops extract 120 mg - formulated for menopausal and post-menopausal women.
How to use
Take 2 capsules daily
Take 2 capsules once per day, or as directed by a qualified health care professional.
Space out other medications
Take a few hours before or after other medications or natural health products.
Check in for long-term use
Consult a health care practitioner for use beyond one year. Do not exceed the daily dose unless instructed by a healthcare practitioner.
What the research says about menopause botanicals
Educational summaries of published research on flaxseed lignans, soy isoflavones, black cohosh and hops; not product-specific claims. AOR Fem-Adapt's claim is the traditional/authorized use under NPN 80034694.
Black cohosh, soy isoflavones and lignans studied together
In a 90-day randomized, double-blind, placebo-controlled trial, 96 postmenopausal women took a combined black cohosh, soy isoflavone and SDG lignan supplement, tracked with the Menopause Rating Scale to assess symptom change versus placebo.
Human RCTA phytoestrogen blend studied for climacteric symptoms
In a randomized, single-blind trial, 48 women aged 40-65 with climacteric symptoms consumed a cereal bar containing a phytoestrogen blend for 90 days to evaluate the effect on menopausal symptom scores.
Human RCTA major review finds moderate-certainty evidence for black cohosh
A systematic review of 158 studies commissioned to help update International Menopause Society guidance found moderate-certainty evidence supporting black cohosh for vasomotor and menopausal symptoms.
Systematic ReviewEvaluating the evidence quality behind black cohosh
This review assessed the quality of clinical evidence for Actaea racemosa (black cohosh), a herbal medicine widely used by women seeking relief from climacteric complaints, applying CONSORT reporting standards for herbal trials.
Evidence ReviewNo signal for weight gain across 1,839 women
A systematic review of adverse-event reports and 31 clinical studies covering 1,839 women treated with black cohosh for up to 12 months found no consistent evidence that it causes weight gain.
Systematic ReviewA black cohosh and soy combination improved antioxidant markers
In a 12-week randomized, double-blind, placebo-controlled trial of 110 post-menopausal women, a blend including black cohosh and soy (Glycine max) improved skin elasticity and antioxidant markers (higher glutathione, lower malondialdehyde) versus placebo.
Human RCTMeta-analysis links soy isoflavones to fewer menopausal symptoms
A systematic review and meta-analysis of 12 studies (533 participants) found soy isoflavones were effective for reducing menopausal symptoms, consistent with their estrogen-like and anti-inflammatory activity.
Meta-AnalysisSoy isoflavones linked to better quality of life in climacteric women
A Cochrane-guided systematic review and meta-analysis of randomized controlled trials examined soy isoflavones' effect on menopausal symptoms and quality of life in climacteric-stage women.
Meta-AnalysisHow soy isoflavones may support bone during estrogen decline
This mechanism review describes how soy isoflavones, acting as phytoestrogens, influence osteoblast and osteoclast activity, calcium/vitamin D balance, and oxidative stress pathways relevant to bone health after menopause.
Mechanism ReviewFlaxseed's plant lignans studied in perimenopausal women
In a randomized, placebo-controlled study of 145 perimenopausal women, researchers evaluated flaxseed supplementation's effect on perimenopausal symptoms alongside blood levels of the lignan metabolites enterodiol and enterolactone.
Human RCTFlaxseed's lignans among its broader health-promoting compounds
This review describes flaxseed (Linum usitatissimum) as a source of alpha-linolenic acid, lignans and fiber, highlighting its role in supporting healthy lipid profiles as part of a balanced diet.
ReviewA clinical-trial review of flaxseed's bioactive components
This review of clinical trials summarizes flaxseed's bioactive components - lignans, alpha-linolenic and linoleic acid, and fiber - and the health outcomes studied across metabolic and cardiovascular endpoints.
Clinical Trial ReviewA year-long trial of hop extract in osteopenic women
In a one-year, double-blind, placebo-controlled trial, 100 postmenopausal women with osteopenia received calcium and vitamin D with or without a hop extract standardized in the phytoestrogen 8-prenylnaringenin, evaluating bone status and the gut microbiome's role.
Human RCTChecking hop extract for drug interactions
Sixteen peri- and postmenopausal women taking a standardized hop extract were assessed for Phase I pharmacokinetic drug interactions, since the plant's prenylated phenols have long half-lives and can inhibit certain cytochrome P450 enzymes - part of the basis for advising a gap between hop-containing supplements and medications.
Human PK StudyMapping the biological targets of hop compounds
This review surveys the bioactive prenylated flavonoids concentrated in hops, including the phytoestrogen 8-prenylnaringenin, and the range of biological pathways they interact with.
Mechanism ReviewInsomnia is common in menopause and hard to treat
A systematic review and meta-analysis found chronic insomnia highly prevalent during the menopause transition, linked to impaired quality of life, cognitive complaints and mood disturbances, and compared pharmacological and non-pharmacological treatment approaches.
Meta-AnalysisSleep quality tracks with quality of life after menopause
In 303 postmenopausal women, researchers used validated sleep and quality-of-life questionnaires to examine how sleep difficulties relate to broader wellbeing in midlife.
Clinical StudyA structured program to ease vasomotor symptoms and support mood
In a randomized controlled trial, 50 postmenopausal Korean women completed an eight-session group cognitive behavioral therapy program aimed at reducing vasomotor symptoms and improving psychological wellbeing and quality of life.
Human RCTChecking a soy isoflavone metabolite against hormone-therapy drugs
This study examined whether an S-equol-containing supplement - a compound derived from soy isoflavones - alters the pharmacokinetics of oral hormone therapy drugs used by breast cancer patients experiencing hot flashes and joint pain.
Human PK StudyWeighing what's known about isoflavones and breast tissue
This review examines how dietary isoflavones are absorbed and act at the cellular level, and why their relationship to breast cancer risk remains an actively and carefully studied question rather than a settled one.
Mechanism ReviewManaging hot flashes in women with a breast cancer history
This literature review summarizes the epidemiology and clinical burden of vasomotor symptoms in breast cancer patients and surveys complementary approaches used to manage them, underscoring why women with a breast cancer history are directed to consult their care team before using phytoestrogen-containing products.
Literature ReviewEstrogen's reach goes well beyond reproduction
This review describes estrogen's wide-ranging roles beyond the menstrual cycle - including neuroprotection - and surveys selective, non-classical estrogen-like therapies developed as alternatives to conventional hormone therapy.
ReviewNon-hormonal ways to support estrogen activity as women age
This mini-review evaluated 48 publications on dietary interventions, micronutrients and other non-pharmacological approaches that modulate the body's own estrogen activity in postmenopausal women, reflecting why many women in Western countries look to natural alternatives to hormone therapy.
ReviewUntangling which plant compounds drive estrogenic activity
Using specialized 'knock-out' extracts, this study isolated which specific compounds in botanicals like hops are responsible for estrogenic versus chemopreventive activity, illustrating why standardization matters for consistent effects.
Mechanism ReviewFrequently asked questions
What is AOR Fem-Adapt used for?
Fem-Adapt (NPN 80034694) is a Health Canada licensed natural health product that helps relieve menopause symptoms in menopausal and post-menopausal women.
What are the active ingredients?
Each 2-capsule serving provides flaxseed (Linum usitatissimum) extract 168 mg, soy isoflavone extract 60 mg (24 mg AIE), black cohosh extract 80 mg and LIFENOL hops extract 120 mg.
How do I take it?
Take 2 capsules once daily, or as directed by a qualified health care professional. Take a few hours before or after other medications or natural health products.
Is Fem-Adapt vegan?
Yes. The capsule shell is hypromellose (vegan) and the formula is non-GMO and gluten-free.
Who should not take Fem-Adapt?
Do not use if you are pregnant, if you currently have or previously had breast cancer or breast tumours, have a predisposition to breast cancer as indicated by an abnormal mammogram or biopsy, or have a family member with breast cancer. Ensure you are up to date on mammograms and gynecological evaluations before use. Contains corn- and soy-derived ingredients.
How long can I take Fem-Adapt?
Consult a health care practitioner for use beyond one year. Do not exceed the daily dose unless instructed by a healthcare practitioner.
How long does one bottle last?
Each bottle contains 60 vegan capsules - a 1-month supply at the recommended dose of 2 capsules daily.
Is Fem-Adapt the same as AOR's other women's health products?
No. Fem-Adapt's formula (flaxseed, soy isoflavone, black cohosh and LIFENOL hops) is distinct from AOR's other women's-health formulas, which use different ingredient combinations for different needs.
Get a 4-part botanical blend for menopause comfort and hormonal balance
Get AOR Fem-Adapt on Amazon.ca - fast, protected delivery.
Get it on Amazon.caNatural Health Product NPN 80034694. Fem-Adapt provides a botanical blend (per 2-capsule serving: flaxseed extract 168 mg, soy isoflavone extract 60 mg, black cohosh extract 80 mg, LIFENOL hops extract 120 mg) traditionally used in herbal medicine to help relieve menopause symptoms in menopausal and post-menopausal women. The research summaries below concern these ingredients generally and are educational - they are not claims about this finished product. Read and follow the label. Ensure you are up to date on mammograms and gynecological evaluations prior to use. Do not use if you are pregnant, if you currently have or previously had breast cancer or breast tumours, have a predisposition to breast cancer, or have a family member with breast cancer. Contains corn- and soy-derived ingredients. Results may vary.
Important information
Safety Information
Cautions: Ensure you are up to date on mammograms and gynecological evaluations prior to use. Do not use if you are pregnant, if you currently have or previously had breast cancer or breast tumours, have a predisposition to breast cancer as indicated by an abnormal mammogram, biopsy or have a family member with breast cancer. This product contains corn and soy derived ingredients, do not use if you have such allergies.
Indications
Recommended Use or Purpose (menopausal and post-menopausal women): Helps relieve menopause symptoms.
Ingredients
Medicinal Ingredients (per 2 capsules): Linum usitatissimum extract (Flax seed) (40:1) 168 mg, Soy Isoflavone extract (Total isoflavones 40%) 60 mg (24 mg AIE*), Black Cohosh extract (6-8:1) 80 mg, LIFENOL® Hops extract (15-30:1) 120 mg. *AIE: Aglycone Isoflavone Equivalents. LIFENOL® is a registered trademark of Naturex, Inc. Non-medicinal Ingredients: Microcrystalline cellulose, silicon dioxide, maltodextrin and tricalcium phosphate. Capsule: hypromellose. NMIs are subject to change - always read and follow the label.
Directions
Recommended Dose (menopausal and post-menopausal women): Take 2 capsules daily, or as directed by a qualified health care professional. Take a few hours before or after taking other medications or natural health products. Consult a health care practitioner for use beyond one year. Do not exceed daily dose unless instructed by a healthcare practitioner.
Legal Disclaimer
Actual product packaging and materials may contain more and different information than shown on our website. Always read labels, warnings and directions before using or consuming a product. This item is sold and shipped by Amazon.ca; purchases are completed on Amazon.